Zinc in PDB 6p6q: Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir

Enzymatic activity of Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir

All present enzymatic activity of Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir:
3.4.21.98; 3.6.1.15; 3.6.4.13;

Protein crystallography data

The structure of Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir, PDB code: 6p6q was solved by J.Timm, C.A.Schiffer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.95 / 3.50
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 49.750, 58.968, 65.891, 90.00, 100.27, 90.00
R / Rfree (%) 22 / 25.8

Zinc Binding Sites:

The binding sites of Zinc atom in the Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir (pdb code 6p6q). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir, PDB code: 6p6q:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in 6p6q

Go back to Zinc Binding Sites List in 6p6q
Zinc binding site 1 out of 2 in the Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1302

b:52.9
occ:0.64
SG A:CYS1145 2.5 83.0 1.0
SG A:CYS1097 2.5 50.6 1.0
CB A:CYS1145 3.0 37.8 1.0
CB A:CYS1097 3.0 53.6 1.0
HA A:CYS1097 3.2 66.5 1.0
HB3 A:ALA1147 3.4 71.6 1.0
CA A:CYS1097 3.6 55.4 1.0
H A:CYS1099 3.6 71.9 1.0
H A:THR1098 4.1 77.5 1.0
CB A:ALA1147 4.3 59.7 1.0
H A:ALA1147 4.3 41.2 1.0
C A:CYS1097 4.4 58.2 1.0
CB A:CYS1099 4.4 67.4 1.0
HB2 A:ALA1147 4.4 71.6 1.0
N A:THR1098 4.4 64.6 1.0
N A:CYS1099 4.5 59.9 1.0
CA A:CYS1145 4.5 34.5 1.0
N A:HIS1149 4.5 51.0 1.0
CA A:HIS1149 4.6 41.5 1.0
HB1 A:ALA1147 4.7 71.6 1.0
HA A:CYS1145 4.8 41.5 1.0
H A:GLY1148 4.8 57.4 1.0
H A:CYS1145 4.8 39.6 1.0
N A:CYS1097 4.8 42.2 1.0
CA A:CYS1099 4.9 63.3 1.0
HD2 A:PRO1146 5.0 52.6 1.0

Zinc binding site 2 out of 2 in 6p6q

Go back to Zinc Binding Sites List in 6p6q
Zinc binding site 2 out of 2 in the Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Hcv NS3/4A Protease Domain of Genotype 1A3A Chimera in Complex with Grazoprevir within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn1302

b:57.4
occ:1.00
SG B:CYS1145 2.4 41.9 1.0
ND1 B:HIS1149 2.7 42.8 1.0
CB B:HIS1149 3.3 34.1 1.0
SG B:CYS1097 3.4 0.0 1.0
CG B:HIS1149 3.4 47.4 1.0
CB B:CYS1145 3.4 35.7 1.0
HB3 B:ALA1147 3.5 64.4 1.0
HA B:CYS1097 3.5 56.8 1.0
CE1 B:HIS1149 3.7 43.7 1.0
H B:HIS1149 3.9 47.6 1.0
CB B:CYS1097 4.1 49.4 1.0
CA B:CYS1097 4.3 47.3 1.0
O B:CYS1099 4.3 71.0 1.0
CB B:ALA1147 4.4 53.6 1.0
H B:ALA1147 4.4 32.0 1.0
HB2 B:ALA1147 4.5 64.4 1.0
H B:THR1098 4.5 55.7 1.0
CA B:HIS1149 4.5 28.7 1.0
CD2 B:HIS1149 4.6 54.6 1.0
CB B:CYS1099 4.6 63.9 1.0
N B:HIS1149 4.6 39.7 1.0
H B:CYS1099 4.7 87.4 1.0
NE2 B:HIS1149 4.7 45.5 1.0
O B:HOH1409 4.8 34.4 1.0
H B:CYS1145 4.8 28.7 1.0
CA B:CYS1145 4.9 32.8 1.0
HB1 B:ALA1147 4.9 64.4 1.0
N B:THR1098 4.9 46.4 1.0
O B:HIS1149 5.0 18.2 1.0
N B:CYS1099 5.0 72.8 1.0

Reference:

J.Timm, K.Kosovrasti, M.Henes, F.Leidner, S.Hou, N.Kurt-Yilmaz, C.A.Schiffer. Molecular Mechanism of Pan-Genotypic Hcv NS3/4A Protease Inhibition By Glecaprevir and Characterization of Genotype-Specific Structural Differences To Be Published.
Page generated: Wed Dec 16 12:28:57 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy